Device Trial Radar · NCT07805798
Urinary Bladder Matrix (UBM) Registry
Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Aug 31, 2026
Primary completion
Aug 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Integra LifeSciences CorporationPublic (IART)
- Sponsor type
- Industry
- First posted
- Sep 4, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.
Conditions
- Tissue Repair
- Soft Tissue Reconstruction
- Wound Management
- Pressure Ulcer (PU)
- Necrotizing Soft Tissue Infection
- Fournier's Gangrene
- Pilonidal Cyst
- Open Abdomen
- Hidradenitis Suppurativa (HS)
- Lower Extremity Wound
- Incisional
Interventions
Urinary Bladder Matrix (UBM) ProductsDevice
Commercially available UBM wound management products used as part of routine clinical practice. Treatment selection, application frequency, and wound management approach are determined by the treating clinician and are not dictated by the registry protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Complete Wound ClosureTime frame: Up to 12 months following the initial UBM application.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.